Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 1, 2005, Pages 39-46

  Kasamon, Yvette L ^a   Jones, Richard J ^a   Diehl, Louis F ^a   Nayer, Hassan ^a   Borowitz, Michael J ^a   Garrett Mayer, Elizabeth ^a   Ambinder, Richard F ^a   Abrams, Ross A ^a   Zhang, Zhe ^a   Flinn, Ian W ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Allogeneic transplantation; Autologous transplantation; Mantle cell lymphoma

Indexed keywords

4 HYDROXYCYCLOPHOSPHAMIDE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER REGISTRY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG MEGADOSE; FEMALE; GRAFT VERSUS HOST REACTION; HAZARD ASSESSMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MULTIPLE REGRESSION; PATHOLOGY; PREDICTION; PROBABILITY; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; WHOLE BODY RADIATION;

ADULT; AGED; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROBABILITY; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 19944428129     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.09.007     Document Type: Article

References (30)

1. M. Schwonzen C. Pohl T. Steinmetz et al. Immunophenotyping of low-grade B-cell lymphoma in blood and bone marrow: Poor correlation between immunophenotype and cytological/histological classification Br J Haematol. 83 1993 232-239
2. S.M. Baidas B.D. Cheson J. Kauh M. Ozdemirli Mantle cell lymphoma: clinicopathologic features and treatments Oncology (Huntingt) 17 2003 879-891 896; discussion 896-878
3. E. Zucca E. Roggero G. Pinotti et al. Patterns of survival in mantle cell lymphoma Ann Oncol. 6 1995 257-262
4. W. Hiddemann M. Dreyling M. Preundschuh et al. Myeloablative radiochemotherapy followed by autologous blood stem cell transplantation leads to a significant prolongation of the event-free survival in patients with mantle cell lymphoma (MCL) - results of a prospective randomized European Intergroup study Blood 98 2001 861a (abstr. 3572)
5. A.S. Freedman D. Neuberg J.G. Gribben et al. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: No evidence for long-term remission J Clin Oncol. 16 1998 13-18
6. J.W. Sweetenham Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials? Bone Marrow Transplant. 28 2001 813-820
7. N. Ketterer G. Salles D. Espinouse et al. Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma Ann Oncol. 8 1997 701-704
8. J.G. Berdeja R.J. Jones M.L. Zahurak et al. Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma Biol Blood Marrow Transplant. 7 2001 561-567
9. I.F. Khouri M.S. Lee J. Romaguera et al. Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy Ann Oncol. 10 1999 1293-1299
10. E. Vandenberghe C.R.D. Elvira P. Isaacson et al. Does transplantation improve outcome in mantle cell lymphoma (MCL)? A study from the EBMT Blood 96 2000 482a (abstr. 2072)
11. S.P. Robinson A.H. Goldstone S. Mackinnon et al. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: An analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation Blood 100 2002 4310-4316
12. I.F. Khouri M.S. Lee R.M. Saliba et al. Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma J Clin Oncol. 21 2003 4407-4412
13. E.S. Jaffe N.L. Harris H. Stein J.W. Vardiman (Eds.). World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001 IARC Press Lyon
14. J.E. Wagner G.W. Santos S.J. Noga et al. Bone marrow graft engineering by counterflow centrifugal elutriation: Results of a phase I-II clinical trial Blood 75 1990 1370-1377
15. E.L. Kaplan P. Meier Non-parametric estimation from incomplete observations J Am Stat Assoc. 53 1958 457-481
16. N. Mantel W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst. 22 1959 719-748
17. R. Tarone J. Ware On distribution-free tests for equality of survival distributions Biometrika 64 1977 156-160
18. D.R. Cox Regression models and life-tables (with discussion) J R Stat Soc B. 34 1972 187-220
19. A.M. Yeager H. Kaizer G.W. Santos et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide N Engl J Med. 315 1986 141-147
20. J.M. Vose P.J. Bierman D.D. Weisenburger et al. Autologous hematopoietic stem cell transplantation for mantle cell lymphoma Biol Blood Marrow Transplant. 6 2000 640-645
21. E. Vandenberghe C. Ruiz de Elvira F.R. Loberiza et al. Outcome of autologous transplantation for mantle cell lymphoma: A study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries Br J Haematol. 120 2003 793-800
22. D. Decaudin N. Brousse P. Brice et al. Efficacy of autologous stem cell transplantation in mantle cell lymphoma: A 3-year follow-up study Bone Marrow Transplant. 25 2000 251-256
23. P. Dreger S. Martin R. Kuse et al. The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: A joint analysis of two prospective studies with 46 patients Hematol J. 1 2000 87-94
24. N. Milpied F. Gaillard P. Moreau et al. High-dose therapy with stem cell transplantation for mantle cell lymphoma: Results and prognostic factors, a single center experience Bone Marrow Transplant. 22 1998 645-650
25. S.K. Sohn W. Sensinger L. Holmberg et al. High dose therapy with allogeneic or autologous stem cell transplantation for relapsed mantle cell lymphoma: The Seattle experience Proc Am Soc Clin Oncol. 17 1998 17a (abstr. 64)
26. R.J. Jones R.F. Ambinder S. Piantadosi G.W. Santos Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation Blood 77 1991 649-653
27. J.E. Levine R.E. Harris F.R. Loberiza Jr et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma Blood 101 2003 2476-2482
28. G. Akpek R.F. Ambinder S. Piantadosi et al. Long-term results of blood and marrow transplantation for Hodgkin's lymphoma J Clin Oncol. 19 2001 4314-4321
29. F. Lefrere A. Delmer F. Suzan et al. Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: A prospective study Leukemia 16 2002 587-593
30. A.J. Peniket M.C. Ruiz de Elvira G. Taghipour et al. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation Bone Marrow Transplant. 31 2003 667-678